Attachment 3 Highlights of Prescribing Information -ROSUVASTATIN
FDA-2026-P-5994-0005Supporting & Related Material
Document
Details
The document's own metadata, straight from the source system.
- Title
- Attachment 3 Highlights of Prescribing Information -ROSUVASTATIN
- Posted
- May 28, 2026
- Topics